Title Physician

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC (CONTACT-02)

NCT ID : 04446117
Protocol Number : XL184-315
Phase : 3
Location : Santa Monica, CA
Dr. Przemyslaw Twardowski

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

NCT ID : 04519879
Protocol Number : White Button Mushroom
Phase : 2
Location : Santa Monica, CA
Dr. Przemyslaw Twardowski

Evaluation of the PhageTech Virus BioResistor

NCT ID : 04756284
Protocol Number : VBRm BCA-01
Phase : Pilot/Feasibility
Location : Santa Monica, CA
Jennifer Linehan, M.D.

A Phase 3 Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (ATLAS)

NCT ID : 04688931
Protocol Number : BL006
Phase : 3
Location : Santa Monica, CA
Jennifer Linehan, M.D.

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

NCT ID : 04586231
Protocol Number : Merck -6482-011
Phase : 3
Location : Santa Monica
Dr. Twardowski

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

NCT ID : 04291105
Protocol Number : VYR-VSV2-203
Phase : 2
Location : Santa Monica, CA
Dr. O'Day

Enfortumab Vedotin and Pembrolizumab, With or Without Chemotherapy, vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer (EV-302)

NCT ID : 04223856
Protocol Number : SGN22E-003
Phase : 3
Location : Santa Monica, CA
Dr. Twardowski

⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors

NCT ID : 03802123
Protocol Number : IAB-CD8-201
Phase : 2
Location : Santa Monica, CA
Dr. Przemyslaw Twardowski

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer

NCT ID : 04186819
Protocol Number : BED-PSMA-301
Phase : 3
Location : Santa Monica, CA
Dr. Twardowski and Dr. Hanelin

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905)

NCT ID : 03924895
Protocol Number : MK-3475-905/KEYNOTE-905/EV-303
Phase : 3
Location : Santa Monica, CA
Dr. Twardowski

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

NCT ID : 03924856
Protocol Number : MK-3475-866/KEYNOTE-866
Phase : 3
Location : Santa Monica, CA
Dr. Twardowski

A Phase I Study of AGEN1181, an Fe-Engineered Anti-CTLA-4 Monoclonal Antibody as Monotherapy and in Combination with AGEN2034, an Anti-PD-1 Monoclonal Antibody, in Subjects with Advanced Cancer

NCT ID : 03860272
Protocol Number : C-800-01
Phase : 1
Location : Santa Monica, CA
Dr. O'Day

Intratumoral AST-008 Combined With Pembrolizumab in Patients With Advanced Solid Tumors

NCT ID : 03684785
Protocol Number : AST-008-102
Phase : 1b/2
Location : Santa Monica, CA
Dr. O'Day